Phreesia, Inc. (PHR)

NYSE • Healthcare

$10.81

+$0.15 (+1.4%)

Market closed

Last close at October 9, 2026 at 20:00 UTC

Open$10.7

Day Range$10.56 - $10.82

Avg. Volume (3M)682.1K

Market Cap$668.1M

P/E Ratio63.6

52 Week Range

$7.77$24.07

Next EarningsIn 65 daysDec 14, 2026

Metrics Over Time

Where the Money Goes

Q3 2026

Revenueeverything earned$129.4M100%

Gross Profitminus cost of goods$76.1M59%

Operating Incomeminus R&D and overhead$11M9%

Net Incomeminus taxes and the rest$1.9M1%

In plain terms: out of every $100 in revenue, Phreesia, Inc. keeps $1 as net profit.

Fundamentals & Financials

Revenue (TTM)

$507.7M

Net Income (TTM)

$10.4M

EPS (TTM)

$0.17

ROA (TTM)

1.61%

Current Ratio

1.76

Dividend Yield

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

+114.3%Q3 2025$0.01

+27877.8%Q4 2025$0.1

-67.4%Q1 2026$0.02

+150.0%Q2 2026$0.05

-64.7%Q3 2026$0.03

Dec 14

in 65 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Miss -64.7%

Phreesia’s revenue rose 10.4% to about $129.5 million, while EPS of $0.03 trailed the $0.09 estimate (-65%) even as revenue of $129.5 million came in line with the $129.1 million consensus (+0.3%) for the second fiscal quarter of 2027 (period ended July 31, 2026) reported September 2, 2026, based on preliminary results. The top line was up from roughly $117.3 million a year ago, and GAAP net income increased 597.2% year over year to about $4.6 million (from roughly $0.7 million a year ago), alongside EPS up from $0.01 in the prior-year period. Cash generation was reflected in operating cash flow of about $18.3 million. For the next period, consensus calls for EPS of $0.12 on revenue of $128.1 million.

View full earnings history

About Phreesia, Inc.

Phreesia, Inc. (NYSE: PHR) provides healthcare software and payment tools for medical practices and health systems in the United States and Canada. Operating in healthcare information services, it generates $480.6 million of revenue in FY2026 through a cloud-based platform that handles patient intake, registration, and related administrative workflows.

Name

Phreesia, Inc.

CEO

Chaim Indig

Website

www.phreesia.com

Industry

Healthcare

Year Founded

2005

Employees

1,789

Today's Snapshot

AI-generated

PHR closed 1.4% above yesterday's close, in line with a firmer sector.

Trading Volume

Below 10d avg (579.4K)

424.6K

vs S&P 500 Today

Outperforming Market

+0.82%

Updated: October 9, 2026 at 20:07 UTC

Technical Indicators

3 Buy2 Neutral3 Sell

PHR is trading slightly above ten dollars but carries a sell posture driven by mixed signals: short-term momentum readings are positive while overbought oscillators and a price sitting above the upper Bollinger Band point to exhaustion. The ADX indicates a weak trend, so near-term strength lacks conviction, and the stock remains below key longer-term averages such as the 50- and 200-day, which weighs on the broader picture. Volume (OBV) offers a mild counterpoint, but it does not offset the overbought technicals and medium/long-term moving average resistance. Technical takeaway: mixed short-term strength but medium-to-long-term averages and overbought readings justify a sell stance.

All signals